| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | May 17, 2022 | Sale | $8.22 | 130,000 | 1,068,067 | 1,387 | May 19, 2022, 07:31 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 04, 2022 | Sale | $7.48 | 24,638 | 184,354 | 111,264 | Mar 08, 2022, 04:07 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 07, 2022 | Sale | $7.37 | 8,941 | 65,866 | 126,087 | Mar 08, 2022, 04:07 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 28, 2022 | Sale | $8.14 | 7,590 | 61,799 | 65,509 | Mar 02, 2022, 07:47 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 09, 2022 | Sale | $9.06 | 6,116 | 55,412 | 51,417 | Feb 10, 2022, 04:09 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Aug 10, 2021 | Sale | $9.95 | 50,860 | 506,021 | 41,412 | Aug 12, 2021, 04:04 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | May 11, 2021 | Sale | $10.22 | 19,066 | 194,830 | 92,272 | May 13, 2021, 07:45 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 04, 2021 | Sale | $10.57 | 9,515 | 100,536 | 73,454 | Mar 08, 2021, 04:07 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 02, 2021 | Sale | $10.82 | 50,000 | 540,890 | 64,064 | Mar 04, 2021, 04:03 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 01, 2021 | Sale | $10.83 | 10,912 | 118,186 | 114,064 | Mar 02, 2021, 04:05 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 16, 2021 | Sale | $11.12 | 2,098 | 23,336 | 103,294 | Feb 17, 2021, 04:07 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 09, 2021 | Sale | $12.69 | 29,496 | 374,437 | 123,676 | Feb 11, 2021, 04:05 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 17, 2020 | Sale | $7.16 | 514 | 3,682 | 45,695 | Mar 19, 2020, 07:33 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 14, 2020 | Sale | $12.14 | 11,472 | 139,295 | 53,886 | Feb 18, 2020, 07:23 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 10, 2020 | Sale | $12.27 | 5,544 | 68,025 | 33,330 | Feb 11, 2020, 06:57 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Dec 31, 2019 | Sale | $9.92 | 2,459 | 24,396 | 22,754 | Jan 02, 2020, 06:08 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Dec 02, 2019 | Sale | $10.49 | 4,310 | 45,214 | 20,573 | Dec 03, 2019, 06:32 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 18, 2019 | Sale | $16.63 | 356 | 5,919 | 16,843 | Mar 19, 2019, 08:04 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 04, 2019 | Sale | $16.88 | 409 | 6,905 | 16,094 | Mar 05, 2019, 07:16 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Feb 14, 2019 | Sale | $17.67 | 1,841 | 32,529 | 15,338 | Feb 19, 2019, 07:11 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Jan 02, 2019 | Sale | $15.70 | 1,643 | 25,799 | 11,826 | Jan 03, 2019, 07:24 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Nov 30, 2018 | Sale | $21.76 | 933 | 20,304 | 8,829 | Dec 04, 2018, 08:09 AM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 19, 2018 | Sale | $17.88 | 348 | 6,222 | 7,142 | Mar 20, 2018, 04:07 PM | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Global R&D | Mar 05, 2018 | Option Exercise | $19.38 | 1,555 | 30,136 | 7,542 | Mar 06, 2018, 04:12 PM | |
| ACT | Actavis plc | Fridriksdottir Hafrun | SVP, GLOBAL R&D | May 09, 2014 | Option Exercise | $197.05 | 1,269 | 250,056 | 6,914 | May 13, 2014, 05:09 PM | |
| ACT | Actavis, Inc. | Fridriksdottir Hafrun | Sr VP, Global Generics R&D | Sep 30, 2013 | Option Exercise | $144.00 | 5,510 | 793,440 | 5,645 | Oct 02, 2013, 09:03 PM |
Menu